Apollo Hospitals Enterprise earnings calls.

Apollo Hospitals delivered a standout Q1 FY27 with consolidated revenue of ₹7,043 croreCurrent reported value: ₹7,043 crore. No comparable prior figure is available in the source record. (+21Current 21 crore vs previous available quarter 17 crore.% YoY) and PAT of ₹581 croreCurrent reported value: ₹581 crore. No comparable prior figure is available in the source record. (+34Current reported value: 34. No comparable prior figure is available in the source record.% YoY), driven by broad-based volume growth of 13%Current 13%. Reported change: +13pp YoY. across hospitals. Healthcare services revenue hit ₹3,567 crore with established hospitals delivering 25.9% EBITDA margins, reflecting operational leverage and case mix improvement—complex quaternary care now represents 62%Current 62%. Reported change: +2pp YoY. of inpatient net revenues. The digital pharmacy/ diagnostics vertical achieved near break-even at ₹10 croreCurrent ₹10 crore. Reported change: -80% YoY. loss, with break-even expected by Q3. New hospital losses at ₹38 crore for the quarter are tracking within the ₹150 crore annual guidance. Management confirmed hospitals segment is on track for 20% revenue growth this year, with Kodaikanal soft launch in September and revenue ramp from Q3-Q4. Expansion to 14,100 beds by FY31 remains funded by internal accruals. Key risks include regulatory scrutiny on pricing following parliamentary recommendations and insurance business losses expected to persist until Q3.